You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.